UltraSound - Technology Information PortalMonday, 25 March 2019
Info
  Sheets



Out-
      side
 




 
 'MRX 408' 
SEARCH FOR   
 
  12345ABCDEFGHIJKLMNOPQRSTUVWZ
Result : Searchterm 'MRX 408' found in 1 term [] and 1 definition [])
1 - 2 (of 2)     
Result Pages : [1]
US Resources  
UltraSound Technician and Technologist Jobs - Obstetric - Preferential Sites - Gall Bladder - Directories - Prenatal
 
MRX 408InfoSheet: - Contrast Agents - 
Intro, 
Historical Development, 
Microbubbles,
etc.MRI Resource Directory:<br> - Contrast Agents -
 
MRX 408 is an investigational thrombus-specific ultrasound contrast agent for clot detection and sonothrombolysis enhancement. Targeted contrast imaging with this GPIIb receptor-targeted ultrasound contrast agent demonstrated better visualization of thrombus within AV fistulae.
MRX 408 is available (ImaRx LLC) with a mean radius of 1.0 mm and a standard deviation of 0.8 mm.
spacer
• Related Searches:
    • Megas CVX
    • Multi-Frequency Probe
    • Spectral Broadening
    • Apogee 3500
    • Soneo

 Further Reading:
  News & More:
molecular imaging using ultrasoundOpen this link in a new window
   by bjr.birjournals.org    
The role of ultrasound in molecular imaging(.pdf)Open this link in a new window
2003   by bjr.birjournals.org    
US Resources  
Breast - Used and Refurbished UltraSound Equipment - Veterinary UltraSound - Rental - UltraSound Technician and Technologist Schools - Portals
 
ImaRx LLCMRI Resource Directory:<br> - Manufacturers -
 
www.imarx.com

Founded in 1991, ImaRx Pharmaceutical Corp. designs, develops and markets pharmaceuticals for medical imaging (MRI, ultrasound and computed tomography) for the radiological imaging industry.
ImaRx Pharmaceutical Corp., announced 1999 that it has been acquired by E.I DuPont de Nemours & Co., Inc. The terms of the acquisition provide a royalty-free licensing arrangement with a newly-formed company, ImaRx LLC ("LLC"), to pursue and develop new products and technologies for drug and gene delivery independent from DuPont. Yamanouchi Pharmaceutical Co. Ltd., ImaRx' licensee for Asian territories for this product, will continue to develop the product in Asia as DuPont's licensee. ImaRx LLC will have ownership of all other targeted and therapeutic products previously owned by ImaRx, including imaging products outside of diagnostic ultrasound imaging and two other imaging products, SonoRx® and LumenHance® LumenHance®, which are both FDA approved and licensed to BRACCO Diagnostics.

Ultrasound Related Product Lines:
Contrast Agents:
TRADE NAME FOR SALE FOR SALE /
DEVELOPMENT
DEVELOPMENT
Definity®
SonoRx
MRX 408

Contact Information:
MAIL ImaRx LLC
1635 East 18th Street
Tucson AZ 85719-6803 USA
PHONE +1-520-770-1259
spacer

US Resources  
Supplies and Accessories - Resources pool - Databases - UltraSound Technician and Technologist Schools - Portals - Vascular
 
Related Searches:
 • Pie Medical Equipment B.V.
 • Vivid 7 Dimension
 • LOGIQ® 9
 • Sonogram
 • SD 260
SEARCH FOR   
 
  12345ABCDEFGHIJKLMNOPQRSTUVWZ
     1 - 2 (of 2)     
Result Pages : [1]
 Random Page
 
Share This Page
FacebookTwitterLinkedIn

US-TIP    
Community   
User
Pass
Forgot your UserID/Password ?  


Look
      Ups



UltraSound - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • US-TIP • 
Copyright © 2006 - 2018 SoftWays. All rights reserved.
Terms of Use | Privacy Policy | Advertising
 [last update: 2015-03-04 09:17:02]